Vitiligo is caused by the immune system attacking and destroying melanocytes, the cells that produce skin pigment. Affecting roughly 1% of the global population (about 70 million people), it’s classified as an autoimmune condition, but the full picture involves genetics, oxidative stress, nerve signaling, and environmental triggers working together to set the process in motion.
The Immune System Drives the Core Damage
At its root, vitiligo is a T-cell-mediated inflammatory disorder. Specific immune cells in the skin, particularly types called T helper 1 and T helper 2 cells, release a cocktail of inflammatory signals that directly damage melanocytes. These signals do several things at once: they reduce how well melanocytes function, weaken the way melanocytes adhere to surrounding skin cells, and ramp up the metabolic stress inside the melanocytes themselves. The result is that pigment-producing cells either stop working or die off entirely, leaving behind patches of white skin.
What makes this process self-sustaining is a feedback loop. Once the immune attack begins, the damaged melanocytes and surrounding skin cells release their own inflammatory signals, which recruit even more immune cells to the area. This cycle of damage and recruitment is regulated through a specific cellular communication pathway (JAK/STAT signaling) that has become a major target for newer treatments. The pathway helps drive chemokine production, immune cell activation, and continued melanocyte destruction, essentially keeping the disease active once it starts.
Genetics Load the Gun
Vitiligo runs in families, and genome-wide studies have identified dozens of genes that raise susceptibility. Most of these genes don’t control skin color directly. Instead, they govern how the immune system behaves. Several major categories stand out.
- T-cell regulation genes like PTPN22, BACH2, and IL2RA influence how T cells develop, activate, and maintain tolerance to the body’s own tissues. Variants in PTPN22, for example, are also linked to other autoimmune diseases like rheumatoid arthritis and type 1 diabetes.
- Innate immune response genes like IFIH1 and TICAM1 are involved in the body’s antiviral defenses and interferon production. Overactive versions of these pathways may prime the immune system to attack melanocytes.
- Immune cell signaling genes like CD80, UBASH3A, and CLNK affect how immune cells communicate and respond to signals, potentially lowering the threshold for autoimmune activity.
- Regulatory T-cell genes like IKZF4 help control the immune cells responsible for preventing the body from attacking itself. When these regulatory mechanisms falter, autoimmune conditions become more likely.
Having these gene variants doesn’t guarantee you’ll develop vitiligo. They create a predisposition, a biological backdrop that makes it easier for other factors to tip the balance.
Oxidative Stress Weakens Melanocytes
Even before the immune system launches its attack, melanocytes in vitiligo-prone skin are often already under chemical stress. The skin of people with vitiligo accumulates excess hydrogen peroxide, a reactive oxygen molecule that damages cells from the inside out. Normally, enzymes like catalase and glutathione break down hydrogen peroxide before it causes harm. In vitiligo skin, these protective enzymes are depleted or downregulated.
When the antioxidant defenses fail, the buildup of reactive oxygen species damages proteins, disrupts cell signaling, and can trigger melanocyte death directly. This oxidative damage also makes melanocytes more visible to the immune system by altering the proteins on their surface. So oxidative stress doesn’t just weaken melanocytes; it may actually help initiate the autoimmune response that finishes them off.
Environmental and Physical Triggers
For many people, vitiligo first appears or worsens after a specific triggering event. These triggers don’t cause vitiligo on their own, but in someone with the genetic and immunological predisposition, they can set the process in motion.
Chemical exposure is one well-documented trigger. Certain industrial chemicals, particularly phenol-based compounds, can directly alter melanocyte proteins. Monobenzone, a skin-depigmenting agent, works by forming chemical attachments to the tyrosinase protein inside melanocytes and triggering the release of melanocyte components that the immune system then recognizes as foreign. This mechanism explains why workers exposed to phenol-containing products (rubber gloves, adhesives, certain cleaning agents) sometimes develop vitiligo-like depigmentation on their hands and arms first.
Physical skin trauma is another trigger through what’s called the Koebner phenomenon. Cuts, burns, sunburns, tattoos, insect bites, or even repeated friction can cause new vitiligo patches to appear at the injury site, typically within 10 to 20 days. The new patches tend to form in a linear pattern following the line of the wound. Any injury that penetrates through the outer and middle layers of skin can potentially set this off.
Emotional stress also plays a documented role. Stressful events increase levels of catecholamines (the body’s stress hormones, including adrenaline and noradrenaline), which have several downstream effects on melanocytes. Elevated catecholamines can constrict blood vessels in the skin, creating oxygen-poor conditions. They also contribute to hydrogen peroxide production, which feeds back into the oxidative stress pathway. At the same time, stress-related neurotransmitter changes can abnormally activate melatonin receptors at nerve endings in the skin, which directly interferes with pigment production.
Segmental Vitiligo and the Nerve Connection
Most vitiligo appears symmetrically on both sides of the body, but a subtype called segmental vitiligo affects only one area, often following the distribution of a single nerve. This pattern has long suggested that nerve signaling plays a unique role. The neural hypothesis proposes that nerve endings in the skin release excessive catecholamines or other neurotransmitters that are toxic to nearby melanocytes. These chemicals can generate hydrogen peroxide locally, disrupt calcium balance in melanocytes, and interfere with the amino acid precursors needed to build melanin. Segmental vitiligo tends to start earlier in life, spread quickly within its affected zone, and then stabilize, which fits with a localized neural trigger rather than a body-wide autoimmune process.
Linked Autoimmune Conditions
Because vitiligo reflects a broader tendency toward autoimmunity, it frequently occurs alongside other autoimmune diseases. Thyroid conditions are the most common overlap. People with vitiligo have roughly 2.6 times the odds of developing Graves’ disease and 1.6 times the odds of Hashimoto’s thyroiditis compared to the general population. Alopecia areata (patchy hair loss) shows a similarly strong association, with about 2.6 times higher odds in vitiligo patients. Type 1 diabetes, pernicious anemia, and rheumatoid arthritis also appear at elevated rates.
These associations matter practically. If you have vitiligo, thyroid function testing is a reasonable part of routine health monitoring, since thyroid conditions are common, treatable, and easy to miss in their early stages.
How Vitiligo Is Identified
Diagnosis is primarily visual. Under a Wood’s lamp (a handheld ultraviolet light used in dermatology), vitiligo patches appear strikingly white with sharp borders because the skin completely lacks melanin. This bright, well-defined fluorescence distinguishes vitiligo from other conditions that merely reduce pigment, like pityriasis alba, which shows only a dull, off-white glow under the same light. The distinction matters because truly depigmented skin (melanocytes destroyed) behaves differently and requires different management than hypopigmented skin (melanocytes present but underperforming).